The primary hypothesis of this proposal is that, in addition to nicotinic acetylcholine receptors (nAChRs) on dopamine neurons, nAChRs on GABA and glutamate neurons in the ventral tegmental area (VTA) shape the response to nicotine in mouse models of addiction. We hypothesize that GABA projection neurons expressing nAChRs contribute to the ability of nicotine to alter responses to environmental cues. Further, we hypothesize that nicotine can stimulate glutamatergic cell bodies in VTA, and that this is essential for the sensitivity to dopamine-dependent behaviors and the long-term responses to nicotine. While acute effects of nicotine are mediated through nAChRs, long-lasting changes in brain circuits and behavior result from downstream effects on intracellular signaling molecules. These signaling molecules are well placed to mediate plastic changes downstream of nAChRs. We will identify the role of signaling molecules co-immunoprecipitated with nAChRs in VTA GABA and glutamate neurons.
The specific aims of this proposal are to test the hypothesis that nAChRs on VTA GABA and glutamate neurons are important for the acute and chronic effects of nicotine on circuits and behaviors related to addiction and to identify nAChR-associated signaling molecules in these cell types.
Tobacco smoking is still the major preventable cause of death in the United States, and nicotine is widely accepted to be the primary compound in cigarette smoke responsible for tobacco consumption. Chronic smoking leads to adaptations in nicotinic receptor (nAChR)-associated signaling molecules in specific neuronal types that likely contribute to ongoing smoking and these nAChR-associated signaling pathways may represent novel targets for development of new treatments to help with smoking cessation. We will identify specific neuronal types and proteins that interact with nAChRs, and using molecular techniques, we will determine how these pathways contribute to behaviors related to nicotine addiction.
|Mineur, Yann S; Einstein, Emily B; Bentham, Matthew P et al. (2015) Expression of the 5-HT1A serotonin receptor in the hippocampus is required for social stress resilience and the antidepressant-like effects induced by the nicotinic partial agonist cytisine. Neuropsychopharmacology 40:938-46|
|McClure-Begley, T D; Papke, R L; Stone, K L et al. (2014) Rare human nicotinic acetylcholine receptor ?4 subunit (CHRNA4) variants affect expression and function of high-affinity nicotinic acetylcholine receptors. J Pharmacol Exp Ther 348:410-20|
|Mazei-Robison, Michelle S; Appasani, Raghu; Edwards, Scott et al. (2014) Self-administration of ethanol, cocaine, or nicotine does not decrease the soma size of ventral tegmental area dopamine neurons. PLoS One 9:e95962|
|Higley, Michael J; Picciotto, Marina R (2014) Neuromodulation by acetylcholine: examples from schizophrenia and depression. Curr Opin Neurobiol 29:88-95|
|Mineur, Yann S; Taylor, Seth R; Picciotto, Marina R (2014) Calcineurin downregulation in the amygdala is sufficient to induce anxiety-like and depression-like behaviors in C57BL/6J male mice. Biol Psychiatry 75:991-8|
|Taylor, Seth R; Badurek, Sylvia; Dileone, Ralph J et al. (2014) GABAergic and glutamatergic efferents of the mouse ventral tegmental area. J Comp Neurol 522:3308-34|
|Picciotto, Marina R; Mineur, Yann S (2014) Molecules and circuits involved in nicotine addiction: The many faces of smoking. Neuropharmacology 76 Pt B:545-53|
|Jung, Yonwoo; Mulholland, Patrick J; Wiseman, Shari L et al. (2013) Constitutive knockout of the membrane cytoskeleton protein beta adducin decreases mushroom spine density in the nucleus accumbens but does not prevent spine remodeling in response to cocaine. Eur J Neurosci 37:1-9|
|Yang, Yang; Paspalas, Constantinos D; Jin, Lu E et al. (2013) Nicotinic *7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortex. Proc Natl Acad Sci U S A 110:12078-83|
|Neugebauer, Nichole M; Einstein, Emily B; Lopez, Maria B et al. (2013) Morphine dependence and withdrawal induced changes in cholinergic signaling. Pharmacol Biochem Behav 109:77-83|
Showing the most recent 10 out of 54 publications